Do you want to read an article? Please log in or register.
ACG Clinical Guideline Update: Ulcerative Colitis in Adults
Inflammatory Bowel Disease
RECOMMENDED
Related content
RECOMMENDED
Inflammatory Bowel Disease
ACG Clinical Guideline: Management of Crohn's Disease in Adults
★ 2
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Lichtenstein GR, Loftus EV, Afzali A, Long MD, Barnes EL, Isaacs KL, Ha CY
doi: 10.14309/ajg.0000000000003465
RECOMMENDED
Inflammatory Bowel Disease
ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease
★ 2
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Farraye FA, Melmed GY, Lichtenstein GR, Barnes EL, Limketkai BN, Caldera F, Kane S
doi: 10.14309/ajg.0000000000003541
Inflammatory Bowel Disease
AGA Clinical Practice Update on Inpatient Management of Adults With Inflammatory Bowel Disease: Expert Review
Gastroenterology
Cohen-Mekelburg S, Hashash JG, Loftus EV Jr, Rubin DT
doi: 10.1053/j.gastro.2025.08.039
Inflammatory Bowel Disease
Placebo rates in randomised clinical trials of ulcerative colitis: An individual patient data meta-analysis
J Crohns Colitis
Solitano V, Hogan M, Singh S, Danese S, Peyrin-Biroulet L, Vuyyuru S, Macdonald JK, Zou G, Yuan Y, Sands BE, Panaccione R, Feagan BG, Hanzel J, Sedano R, Dulai P, Narula N, Ma C, Jairath V
doi: 10.1093/ecco-jcc/jjaf191
RECOMMENDED
Further Publications
European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach
★ 2
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
United European Gastroenterol J
Al-Toma A, Zingone F, Branchi F, Schiepatti A, Malamut G, Canova C, Rosato I, Ocagli H, Trott N, Elli L, Popp A, Gianfrani C, Auricchio R, Neefjes-Borst A, Sanders DS, Cellier C, Mulder CJ, Bouma G, Lundin KEA, Sollid LM, Schumann M
doi: 10.1002/ueg2.70119
Inflammatory Bowel Disease
Mechanistic insights into FMT for the treatment of ulcerative colitis: analysis of the STOP-Colitis trial
J Crohns Colitis
Quraishi MN, Moakes CA, Yalchin M, Blackwell C, Segal J, Ives NJ, Magill L, Manzoor SE, Gerasimidis K, McMullan C, Mathers J, Horniblow R, Loi S, Kaur M, Loman NJ, Sharma N, Hawkey P, McCune V, Quick J, Nicholls S, McMurray C, Nichols B, Svolos V, Raguideau S, Kerbiriou C, Oo YH, Beggs AD, Crees N, Hansen R, Hart AL, Gaya DR, Quince C, Iqbal TH
doi: 10.1093/ecco-jcc/jjag006
Inflammatory Bowel Disease
Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program
Inflamm Bowel Dis
Sands BE, Dubinsky MC, Kotze PG, Vermeire S, Panaccione R, Long MD, Woolcott JC, Wu J, McDonnell A, Goetsch M, Bananis E, Yarur AJ
doi: 10.1093/ibd/izaf036
Inflammatory Bowel Disease
Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis
Inflamm Bowel Dis
Rubin DT, Danese S, Nakase H, Ungaro RC, Wolf DC, Alekseeva O, Petersen A, Liu Z, Mehra D, Jain A, Osterman MT, Krakovich A, Riolo JV, DeBoer E, Appio J, Sinh P, Cree BAC, Cohen JA, Irving P
doi: 10.1093/ibd/izaf319
Inflammatory Bowel DiseaseFurther Publications
Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry
United European Gastroenterol J
Naber MR, van der Meulen AE, Voorneveld PW, Veltkamp SHC, van Bodegraven AA, Bodelier A, Mujagic Z, Pierik M, Verleye LMM, Duijvestein M, Bouwknegt DG, Visschedijk MC, Srivastava N, West RL, Oldenburg B, Löwenberg M, van Schaik FDM, Dutch ICC Registry
doi: 10.1002/ueg2.70141